A Dark Vector Cognition product

Item 16. FORM 10-K SUMMARY.

6K characters. Original on sec.gov · Markdown

Item 16. FORM 10-K SUMMARY.

None.

_____________________________________________________________________91

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

L3HARRIS TECHNOLOGIES, INC.
(Registrant)
Date: February 12, 2026By:/s/ Christopher Kubasik
Christopher Kubasik
Chairman and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

SignatureTitleDate
/s/ CHRISTOPHER KUBASIKChairman and Chief Executive Officer (Principal Executive Officer)February 12, 2026
Christopher Kubasik
/s/ KENNETH BEDINGFIELDSenior Vice President, Chief Financial Officer and President, Missile Solutions (Principal Financial Officer)February 12, 2026
Kenneth Bedingfield
/s/ JOHN CANTILLONVice President, Principal Accounting Officer (Principal Accounting Officer)February 12, 2026
John Cantillon
*DirectorFebruary 12, 2026
Sallie Bailey
*DirectorFebruary 12, 2026
Thomas Dattilo
*DirectorFebruary 12, 2026
Roger Fradin
*DirectorFebruary 12, 2026
Joanna Geraghty
*DirectorFebruary 12, 2026
Kirk Hachigian
*DirectorFebruary 12, 2026
Harry Harris, Jr.
*DirectorFebruary 12, 2026
Lewis Hay III
*DirectorFebruary 12, 2026
Rita Lane
*DirectorFebruary 12, 2026
Robert Millard
*DirectorFebruary 12, 2026
David Regnery
*DirectorFebruary 12, 2026
Edward Rice, Jr.
*DirectorFebruary 12, 2026
Christina Zamarro
  • By Christoph Feddersen pursuant to a Power of Attorney executed by the Directors listed above, which has been filed with this Annual Report on Form 10-K.

Date: February 12, 2026 By: /s/ Christoph Feddersen

Christoph Feddersen, Attorney-in-Fact

_____________________________________________________________________92

Previous: Item 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES.